Mechanistic safety assessment via multi-omic characterisation of systemic pathway perturbations following in vivo MAT2A inhibition
Archives of Toxicology · 2024
DOI: 10.1007/s00204-024-03771-w ↗Kurz gefasst
Fachartikel in der Zeitschrift Archives of Toxicology, 2024. Verfasst von Valentina Fogal und 21 weiteren Autor:innen. Beteiligte Einrichtung: Oncology Safety, Safety Sciences, Clinical Pharmacology & Safety Sciences, R&D, AstraZeneca, Cambridge, UK. Hauptthemen laut MEDLINE: Methionine Adenosyltransferase, S-Adenosylmethionine. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Daphne Jackson Trust.
Abstract (Originalsprache)
The tumour suppressor p16/CDKN2A and the metabolic gene, methyl-thio-adenosine phosphorylase (MTAP), are frequently co-deleted in some of the most aggressive and currently untreatable cancers. Cells with MTAP deletion are vulnerable to inhibition of the metabolic enzyme, methionine-adenosyl transferase 2A (MAT2A), and the protein arginine methyl transferase (PRMT5). This synthetic lethality has paved the way for the rapid development of drugs targeting the MAT2A/PRMT5 axis. MAT2A and its liver- and pancreas-specific isoform, MAT1A, generate the universal methyl donor S-adenosylmethionine (SAM) from ATP and methionine. Given the pleiotropic role SAM plays in methylation of diverse substrates, characterising the extent of SAM depletion and downstream perturbations following MAT2A/MAT1A inhibition (MATi) is critical for safety assessment. We have assessed in vivo target engagement and the resultant systemic phenotype using multi-omic tools to characterise response to a MAT2A inhibitor (AZ’9567). We observed significant SAM depletion and extensive methionine accumulation in the plasma, liver, brain and heart of treated rats, providing the first assessment of both global SAM depletion and evidence of hepatic MAT1A target engagement. An integrative analysis of multi-omic data from liver tissue identified broad perturbations in pathways covering one-carbon metabolism, trans-sulfuration and lipid metabolism. We infer that these pathway-wide perturbations represent adaptive responses to SAM depletion and confer a risk of oxidative stress, hepatic steatosis and an associated disturbance in plasma and cellular lipid homeostasis. The alterations also explain the dramatic increase in plasma and tissue methionine, which could be used as a safety and PD biomarker going forward to the clinic.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Oncology Safety, Safety Sciences, Clinical Pharmacology & Safety Sciences, R&D, AstraZeneca, Cambridge, UK.
- Cancer Metabolism & Systems Toxicology Group, Division of Cancer, Department of Surgery and Cancer, Imperial College London, London, UK.
- Bioscience, Research and Early Development, Oncology R&D, AstraZeneca, Cambridge, UK.
- Data Sciences & Quantitative Biology, Discovery Sciences, R&D, AstraZeneca, Cambridge, UK.
- Discovery Biology, Discovery Sciences, R&D, AstraZeneca, R&D Boston, Waltham, USA.
- DMPK, Oncology R&D, AstraZeneca, Cambridge, UK.
ORCID-Profile: Muireann Coen
Förderung
- Daphne Jackson Trust
Zitieren
APA
Fogal, V., Michopoulos, F., Jarnuczak, A. F., Hamza, G. M., Harlfinger, S., Davey, P., Hulme, H., Atkinson, S. J., Gabrowski, P., Cheung, T., Grondine, M., Hoover, C., Rose, J., Bray, C., Foster, A. J., Askin, S., Majumder, M. M., Fitzpatrick, P., Miele, E., …, & Coen, M. (2024). Mechanistic safety assessment via multi-omic characterisation of systemic pathway perturbations following in vivo MAT2A inhibition. Archives of Toxicology. https://doi.org/10.1007/s00204-024-03771-w
Vancouver
Fogal V, Michopoulos F, Jarnuczak AF, Hamza GM, Harlfinger S, Davey P, et al. Mechanistic safety assessment via multi-omic characterisation of systemic pathway perturbations following in vivo MAT2A inhibition. Archives of Toxicology. 2024. doi:10.1007/s00204-024-03771-w
BibTeX
@article{Fogal2024,
author = {Fogal, Valentina and Michopoulos, Filippos and Jarnuczak, Andrew F and Hamza, Ghaith M and Harlfinger, Stephanie and Davey, Paul and Hulme, Heather and Atkinson, Stephen J and Gabrowski, Piotr and Cheung, Tony and Grondine, Michael and Hoover, Clare and Rose, Jonathan and Bray, Chandler and Foster, Alison J and Askin, Sean and Majumder, Muntasir Mamun and Fitzpatrick, Paul and Miele, Eric and Macdonald, Ruth and Keun, Hector C and Coen, Muireann},
title = {Mechanistic safety assessment via multi-omic characterisation of systemic pathway perturbations following in vivo MAT2A inhibition},
journal = {Archives of Toxicology},
year = {2024},
doi = {10.1007/s00204-024-03771-w}
}
EUVIMED